Medical comms - Press Releases

Date	Title	Company
17-Jun-2020	Subcutaneous Formulation of DARZALEX®▼(Daratumumab) Combination Resulted in Deep and Rapid Haematologic Responses and Improved Clinical Outcomes in the Treatment of Patients with Newly Diagnosed Light Chain (AL) Amyloidosis	The Janssen Pharmaceutical Companies of Johnson & Johnson
17-Jun-2020	Celltrion to expand COVID-19 testing portfolio to include both antigen and antibody testing kits	Celltrion Healthcare
17-Jun-2020	New Late-Breaking Data Show Use of Abbott's FreeStyle Libre System Significantly Reduces HbA1c Levels in People with Type 2 Diabetes Using Insulin or Not	Abbott
17-Jun-2020	ADVFN Reveals Most Tracked Stocks During Lockdown	ADVFN
17-Jun-2020	Evelo Biosciences to Present at Virtual BMO 2020 Prescriptions for Success Healthcare Conference	Evelo Biosciences
17-Jun-2020	New Data from Phase 3 Studies Support Maintained Transfusion Independence* for Patients Across Genotypes Treated with betibeglogene autotemcel (LentiGlobin for β-thalassaemia) Gene Therapy	bluebird bio
17-Jun-2020	FDA Grants Breakthrough Device Designation to Thermo Fisher Scientific's Oncomine Precision Assay to Identify IDH1 and IDH2 Mutations in Low-Grade Glioma Patients	The U.S. Food and Drug Administration
17-Jun-2020	Sanofi’s investigational enzyme replacement therapy shows clinically meaningful improvement in critical manifestations of late-onset Pompe disease	Sanofi
17-Jun-2020	Sanofi invests to make France its world class center of excellence in vaccine research and production	Sanofi
17-Jun-2020	Investigational, once-weekly insulin icodec showed comparable efficacy and safety to once-daily insulin glargine U100 in phase 2 trial	Novo Nordisk
17-Jun-2020	Santhera Completes Capital Increase for Financing Arrangements	Santhera Pharmaceuticals
17-Jun-2020	Diaverum continues to grow its international presence by acquiring the CTN clinic in São Paulo, Brazil	Diaverum
17-Jun-2020	FDA Grants Breakthrough Device Designation to Thermo Fisher Scientific's Oncomine Precision Assay to Identify IDH1 and IDH2 Mutations in Low-Grade Glioma Patients	Thermo Fisher Scientific
17-Jun-2020	Gloucestershire Hospitals NHS Trust quickly responds to COVID-19 with Citrix	Gloucestershire Hospitals NHS Trust
17-Jun-2020	Celltrion to expand COVID-19 testing portfolio to include both antigen and antibody testing kits	Celltrion Healthcare
17-Jun-2020	Kancera's drug candidate KAND567 has a positive effect on mobility in a preclinical model of spinal cord injury	Kancera AB
17-Jun-2020	ISA Pharmaceuticals Strengthens Strategic Immuno-Oncology Collaboration with Regeneron	ISA Pharmaceuticals
17-Jun-2020	Regulatory approvals and programme update	ReNeuron Group plc
17-Jun-2020	Call for pharmacists to receive formal training in suicide and self-harm	The University of Huddersfield
17-Jun-2020	PTC Therapeutics Announces the Initiation of a Phase 2/3 Clinical Trial to Evaluate PTC299 for the Treatment of COVID-19	PTC Therapeutics, Inc